Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
02/2009
02/11/2009EP0879244B1 Mycoplasma recombinant polypeptide and vaccines
02/11/2009EP0784059B1 Polynucleotides encoding an antigenic polypeptide of chlamydia pneumoniae
02/11/2009CN101365794A Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress
02/11/2009CN101365793A Polypeptide extracted from plants of the genus lupinus or produced in recombinant form, nucleotide sequence encoding it and its use in animal nutrition, as a plant growth promoter and in the fight aga
02/11/2009CN101365786A Plants having improved growth characteristics and methods for making the same
02/11/2009CN101365785A Process and materials for production of glucosamine and n-acetylglucosamine
02/11/2009CN101365784A Methods of specifying mesodermal, endodermal and mesoendodermal cell fates
02/11/2009CN101365719A Method for removing sialic acid and method for producing asialoerythropoietin
02/11/2009CN101365718A Vascular aging-predicting factor and utilization of the same
02/11/2009CN101365717A Screening method, process for purifying of non-diffusible A-beta oligomers, selective antibodies against said non-diffusible A-beta oligomers and a process for manufacturing of said antibodies
02/11/2009CN101365716A Mu-conotoxin peptides and use thereof as a local anesthetic
02/11/2009CN101365715A Matrix metalloproteinase 11 vaccine
02/11/2009CN101365714A Tuberculosis antigen detection assays and vaccines
02/11/2009CN101365713A Porcine circovirus type 2 vaccines
02/11/2009CN101365499A Bone matrix compositions and methods
02/11/2009CN101365492A Transglutaminase mediated conjugation of growth hormone
02/11/2009CN101365481A Canine influenza virus and related compositions and methods of use
02/11/2009CN101365476A Combined use of dpp iv inhibitors and gastrin compounds
02/11/2009CN101365416A Chimeric keratin-binding effector proteins
02/11/2009CN101363024A Early light-inductive protein gene and preparation method thereof
02/11/2009CN101363012A Method for amplifying hematopoietic stem cell and progenitor cell using rhDSL recombinant protein
02/11/2009CN101363007A Lactic acid bacerium capable of producing resistant protease bacteriocin and culture thereof
02/11/2009CN101362801A Rapid detection test strip for detecting campylobacter jejuni specific antigen
02/11/2009CN101362800A Test strip for rapid detection of brucella
02/11/2009CN101362799A Gene for regulating and controlling plant height and application thereof
02/11/2009CN101362798A Candida albicans hyphal development inhibitor and application thereof
02/11/2009CN100460874C Method for sieving crimp-relevant protain activator or antagonist
02/11/2009CN100460510C Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies
02/11/2009CN100460509C Trichina paramyosin gene and application thereof
02/11/2009CN100460508C Secretory expression for human insulin gene in methyl alcohol yeast
02/11/2009CN100460507C Human tissue factor pathway inhibitory factor mutation gene m0TFPI, recombination carrier and recombination microzyme including the same
02/11/2009CN100460420C Frigostable correlative transcriptive factor of rice and coding gene and application thereof
02/11/2009CN100460014C Helicobacter pylori vaccine based on urease B subunit active segment and prepn process thereof
02/10/2009US7488816 Methods for obtaining thermostable enzymes, DNA polymerase I variants from Thermus aquaticus having new catalytic activities, methods for obtaining the same, and applications of the same
02/10/2009US7488814 Polynucleotides, expression vectors, host cells, biosynthesis of polypeptides, generating antibody responses
02/10/2009US7488809 Chimeric polypeptide comprising the fragment B of shiga toxin and peptides of therapeutic interest
02/10/2009US7488805 Apoptosis proteins
02/10/2009US7488803 Anticancer agents; two primordial germ cell-specific expressed genes, Fragilis and Stella; as markers for primordial germ cells
02/10/2009US7488801 Interferon-alpha polypeptides and conjugates
02/10/2009US7488800 Isolated water soluble VP1 polypeptide of foot and mouth viral disease; containing sequence number 3; cancer, reperfusion injuries; neurodegenerative, autoimmune and immunodeficiency diseases; activating procaspase 9, 7 or 3
02/10/2009US7488799 Prostaglandin receptor protein
02/10/2009US7488798 Cancers of the breast, prostate, colorectal, lung, thyroid, ovaries, and brain as well as in childhood leukaemias, glioblastomas, and neuroblastomas; Insulin-like Growth Factor Binding Protein (IGFBP) with reduced IGF (Insulin-like Growth Factor) release characteristics
02/10/2009US7488796 Cell culturing and expressing the protein, chimeric polypeptides, fusion proteins; membrane protein receptor is used to bind the protein drugs thrombolytic agents, interferons, interleukins, erythropoietins
02/10/2009US7488795 PRO846 polypeptides
02/10/2009US7488793 Isolated peptide which binds to HLA-Cw*07 and uses thereof
02/10/2009US7488791 capable of stimulating the production of anti-HPV T CD4+ lymphocytes for vaccination against uterine of uterus cancer or as diagnostic reagent of HPV-specific T lymphocytes, in particular for assessing the immune condition of patients
02/10/2009US7488718 Synthetic HLA binding peptide analogues and uses thereof
02/10/2009US7488716 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction
02/10/2009US7488715 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
02/10/2009US7488714 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction
02/10/2009US7488711 Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth
02/10/2009US7488710 Proteins containing the motif that are capable of binding to secreted Frizzled-related protein (Sfrp) family members
02/10/2009US7488597 Polynucleotide encoding an intracellular estradiol binding protein
02/10/2009US7488590 Fusion of Fc domains with biologically active peptides; selecting peptide that modulates the activity of AGP-3, preparing a gene construct; expressing the pharmacologically active compound in which an Fc domain is covalently linked to peptide
02/10/2009US7488589 Interferon-alpha polypeptides and conjugates
02/10/2009US7488588 Compounds related to or derived from GFR α4 and their use
02/10/2009US7488586 PRO4409 polypeptides
02/10/2009US7488583 Fragment complementation assays for G-protein-coupled receptors and their signaling pathways
02/10/2009US7488491 Use of glycosylceramides as adjuvants for vaccines against infections and cancer
02/10/2009US7488487 Administering an auxotropic attenuation strain of Listeria which expresses an antigen; induction immunology response; anticancer agents
02/10/2009US7488484 Multimeric protein fo treating and preventing viral infection; immunosuppressant
02/10/2009US7488481 Polypeptides derived from anti-HIV-1 gp120 antibodies that abrogate gp120 binding to CCR5
02/10/2009US7488479 Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer
02/10/2009US7488478 Treating inflammatory joint diseases by inhibiting cadherin-11 mediated cellular function; chronic synovitis, autoimmune diseases, rheumatoid arthritis
02/10/2009US7488476 Peptide with amino acid sequences and biologial homologues or derivatives for vaccines or antibodies
02/10/2009US7488473 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; administering antiviral polypeptide
02/10/2009CA2596983A1 Voltage-gated ion channel mutants for use in identifying ion channel modulating compounds
02/10/2009CA2461133C Method for determining cell cycle position
02/10/2009CA2339299C Method of modulating memory effector t-cells and compositions
02/10/2009CA2331368C Nucleic acid vaccines for prevention of flavivirus infection
02/10/2009CA2329776C Antibody against lar phosphatase subunit
02/10/2009CA2284136C Method and means for modulating plant cell cycle proteins and their use in plant cell growth control
02/10/2009CA2198743C Feline infectious peritonitis vaccine
02/10/2009CA2166318C Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases
02/10/2009CA2165197C Recombinant stratum corneum chymotryptic enzyme (scce)
02/05/2009WO2009018438A1 Protein discovery using intracellular ribosome display
02/05/2009WO2009018333A2 Dha and pedf, a therapeutic composition for nerve and retinal pigment epithelial cells
02/05/2009WO2009018219A2 Methods and compositions for modulating rad51 and homologous recombination
02/05/2009WO2009018126A2 Collagen-related peptides and uses thereof
02/05/2009WO2009017482A1 Collagen-related peptides
02/05/2009WO2009017444A2 Diagnosis, staging and monitoring of inflammatory bowel disease
02/05/2009WO2009017255A1 Method for specific regulation of toll-like receptor/interleukin-18 signaling by mutation-introduced myd88 protein
02/05/2009WO2009017154A1 Method for producing peptide
02/05/2009WO2009017052A1 Osteoarthritis-sensitive gene
02/05/2009WO2009016855A1 Method of preventing hair loss and method of preventing hair depigmentation
02/05/2009WO2009016651A1 Simplified means for obtaining prn from bordetella pertussis
02/05/2009WO2009016643A1 Process for the preparation glatiramer acetate (copolymer-1)
02/05/2009WO2009016627A1 Sex-peptides resistant to proteolytic degradation and their use in biological control of insects
02/05/2009WO2009016326A2 Adeno-associated viral vectors for the expression of dysferlin
02/05/2009WO2009016249A2 Transgenic plants with increased stress tolerance and yield
02/05/2009WO2009016212A2 Plants having enhanced yield-related traits and a method for making the same
02/05/2009WO2009016178A1 Methods and substances for the treatment of alzheimer's
02/05/2009WO2009016104A1 Plants having enhanced yield-related traits and a method for making the same
02/05/2009WO2009016043A2 New albumin binding compositions, methods and uses
02/05/2009WO2009015904A1 Fluorescent gfp variant displaying highly increased fluorescence intensity without a spectral shift
02/05/2009WO2009015884A1 Glycosaminoglycan-antagonising mcp-1 mutants and methods of using same
02/05/2009WO2009015842A2 Novel immunogenic epitopes for immunotherapy
02/05/2009WO2009015840A2 Polypeptide for targeting of neural cells
02/05/2009WO2009015736A1 Optimized purification process of recombinant growth factor protein
02/05/2009WO2009015696A1 High sensitivty immunoassays and kits for the determination of peptides and proteins of biological interest